Werewolf Therapeutics HOWL
NASDAQ HOWL
$1.03 -0.02 (-1.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Werewolf Therapeutics (HOWL) Preferred Stock Liabilities (2020 - 2021)

Updated

Werewolf Therapeutics' Preferred Stock Liabilities came in at $118.77 million for Q1 2021, up 248.6% from $34.07 million a year earlier but down 15.8% from the prior quarter.

Analysis

Werewolf Therapeutics (HOWL) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Werewolf Therapeutics' Preferred Stock Liabilities was $141.08 million.

  • The five-year range for quarterly Preferred Stock Liabilities is $34.07 million (Q1 2020) to $141.08 million (Q4 2020).
  • Business Quant data shows HOWL's Preferred Stock Liabilities at $141.08 million (Q4 2020), $56.17 million (Q3 2020) and $56.17 million (Q2 2020) in the three quarters before Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Werewolf Therapeutics 49.57 Mn -141.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 118.77 Mn
Dec 31, 2020 141.08 Mn
Sep 30, 2020 56.17 Mn
Jun 30, 2020 56.17 Mn
Mar 31, 2020 34.07 Mn
API Access

Werewolf Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=HOWL&period=max&api_key=YOUR_API_KEY